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Abstract 
Vaccination of rainbow trout against Enteric Redmouth Disease (ERM) caused by Yersinia ruckeri 
can be successfully performed by administering vaccine (a bacterin consisting of formalin killed 
bacteria) by immersion, bath or injection. Booster immunization is known to increase the protection 
of fish already primed by one of these vaccination methods. Oral vaccination of trout (administering 
vaccine in feed) is an even more convenient way of presenting antigen to the fish but the effect of 
an oral booster has not previously been described in detail. The present work describes to what 
extent protection may be enhanced by oral boostering following priming with different 
administration methods. The study confirms that vaccination by 30 sec dip into a bacterin (diluted 
1:10) may confer a significant protection compared to non-vaccinated fish. The immunity may be 
optimized by booster immunization either provided as dip (most effective), bath (less effective) or 
orally (least effective). Oral immunization may be used as booster after dip but applied as a single 
oral application it induced merely a slight and statistically non-significant response. It is noteworthy 
that primary oral immunization followed by an oral booster vaccination showed a trend for an even 
weaker response. It should be investigated if continued exposure to a low antigen concentration – as 
performed by two oral immunizations - may induce tolerance to the pathogen and thereby leave the 
fish more vulnerable.    
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Introduction 
Enteric Redmouth Disease ERM is caused by the enterobacterium Yersinia ruckeri and is 
considered one of the most problematic diseases leading to severe economical losses in freshwater 
farming of salmon and trout [1]. Clinical signs are bleedings in the mouth, surface tissues 
(particularly fins and fin bases) and at necropsy hemorrhages are also detected in internal organs 
including the gastro-intestinal tract [2, 3]. The disease can be treated by use of various antibiotics 
but already decades ago vaccination methodologies were tested with some success in traditional 
trout farms [4-6]. These classical immunoprophylactic studies were performed with the use of 
formalin killed Y. ruckeri bacteria (bacterin) and administration method studies showed that the way 
of presenting Y. ruckeri antigens to rainbow trout has an important effect on the protective response. 
Intraperitoneal vaccine injection led to a superior effect compared to dip of trout into the bacterin 
[5, 7]. However, protection conferred by dip vaccination may be further improved by booster 
vaccination either by re-dipping for 30 sec or by bathing fish in a diluted bacterin for at least one 
hour [8, 9]. Still injection and dip vaccination procedures are time consuming and if the antigens 
could be supplied with the fish feed it would reduce handling of fish and labor during vaccination 
procedures. Oral presentation of Y. ruckeri antigens to trout has been tested previously [10, 11] but 
the protection conferred was generally low. However, oral booster vaccination has been suggested 
as a way to increase protection, and a commercial vaccine (AquaVac ERM oral, MSD Animal 
Health) is available, but at present no precise evaluation of this administration method compared to 
dip or bath is available. We have therefore performed a comparative study in order to determine the 
relative protective effect of booster vaccination using dip, bath and oral antigen administration. 
Antibody reactions in the fish were followed by measuring IgM in sera from fish after vaccination 
and after challenge with live Y. ruckeri bacteria.    
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Materials and Methods 
Fish 
A total of 3000 rainbow trout were produced by hatching disinfected trout eggs (7-8 °C) of the 
Rakkeby strain (Jutland, Denmark) and subsequent rearing (12-13 °C) at the Salmon Hatchery, 
Bornholm, Denmark, which is a pathogen-free recirculated facility supplied with municipal 
freshwater [12]. Fish were kept in 14 tanks (1 m3 tanks each containing 700 L municipal 
freshwater) and fed (1% biomass) with commercial standard pelleted feed (Biomar A/S, Brande, 
Denmark).   
Experimental groups and vaccination 
A more comprehensive outline of the schematic overview of the experimental setup can be found in 
the supplementary materials (Fig. S1). Primary vaccination was performed using 6 months old fish 
(2160 degree days) with a mean body weight of 3.5 g. The experimental set-up comprised group 1: 
A total of 1000 rainbow trout kept as unvaccinated control fish, group 2: A total of 1000 rainbow 
trout  immunized by oral vaccination (AquaVac ERM oral, MSD Animal Health) by supplying 
vaccine (0.1 ml/fish) in feed (1% biomass per day) over 2x5 days with a break of 5 days in between 
according to the manufacturer’s recommendations and group 3: A total of 1000 rainbow trout dip 
vaccinated for 30 s with AquaVac® RELERA (MSD Animal Health) vaccine (diluted 1:10) 
containing formalin-inactivated Yersinia ruckeri biotype 1 (5 × 109 cells/ml) and Y. ruckeri (EX5) 
biotype 2 (5 × 109 cells/ml). All fish groups were then kept separately in 1 m3 fish tanks (water 
volume 700 l). Booster vaccination was conducted 45 days post-primary vaccination and four 
additional groups were hereby formed and comprisedgroup4: A total of 200 fish orally vaccinated 
once was orally boostered by giving 0.1 ml vaccine (AquaVac® ERM oral) /fish in feed (2x5 days 
with a break of 5 days on normal feed in between), group 5: A total of 200 fish dip vaccinated once 
were boostered by dip into bacterin (AquaVac® RELERA) diluted 1:10 for 30 sec, group 6: A total 
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of 200 fish vaccinated by dip once was orally booster vaccinated by using AquaVac® ERM oral as 
described above, and group 7: A total of 200 fish dip vaccinated once were boostered by 1 h bath 
(bath vaccination defined as long term exposure to diluted antigen for 1 hour or more) in diluted 
bacterin (1:1000) (AquaVac® RELERA). Control fish were sham vaccinated by immersion into 
pure water and by feeding them with commercial standard pelleted feed (Biomar A/S, Brande, 
Denmark). Thus a total of seven duplicated groups (14 fish tanks) were treated (Table 1).  
Fish infection facility 
For the challenge experiment subsamples of fish from all groups were transported to the fish 
infection facility at the University of Copenhagen, Frederiksberg, Denmark, where they were 
exposed to live bacteria. At arrival the pathogen free status of fish was confirmed by examining two 
fish from each group by standard bacteriological and parasitological examination [13]. Fish were 
acclimatized at 14°C for 14 days before experimentation and fed (1% biomass) with commercial 
standard pelleted feed (BioMar A/S, Brande, Denmark).  
Challenge experiments 
The challenge experiment was performed on day 97 (1358 degree days) post-primary vaccination 
by exposing (using i.p. injection) 3 subgroups of each treatment to three different dosages of Y. 
ruckeri serotype O1 biotype 2 (100415-1/4): 1) low dosage (6.5 x 104 cfu/fish), 2) medium dosage 
(6.5 x 105 cfu/fish) and 3) high dosage (6.5 x 106 cfu/fish), respectively. The Y. ruckeri strain used 
was isolated from a Danish fish farm [14] and further characterized according to Wheeler et al. [15]. 
All exposures were performed in duplicate (2x25 fish). Experimental fish were anesthetized with 
MS222 (50 mg/l) and live bacteria were administered by intraperitoneal injection of 100 µl bacterial 
suspension. After administration of the live bacteria groups of challenged fish were returned to 
individual fish tanks (water volume 100 l). Fish were observed with 2 h intervals following 
challenge and moribund fish were removed, and euthanized in an overdose (300 mg/l) of MS-222 
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(Tricaine methane sulphonate, Sigma-Aldrich). Y. ruckeri O1 biotype 2 was re-isolated from head 
kidney of freshly euthanized fish (2 fish/group) on blood agar plates to confirm that the disease was 
caused by the challenge strain [14].  
Sampling 
Blood sampling was conducted by caudal vein puncture (ten samples per group) at three time 
points: at 52 days (728 degree days) and 90 days (1260 degree days) post primary vaccination/ 45 
days post booster (45 dpb) (before exposure to live bacteria) and at 3 weeks post-challenge (from 
fish exposed to a low dosage of Y. ruckeri) corresponding to 119 days/ 74 dpb (1666 degree days) 
after the primary vaccination. Blood was kept at 4 °C overnight, centrifuged at 3000 g for 10 min (4 
°C), and serum separated and stored at -80 °C until measurement of specific antibody levels against 
Y. ruckeri.  
Antibody analysis  
Specific antibody in fish raised against Y. ruckeri was measured by ELISA according to Chettri et 
al. [7, 16]. In brief, a 48 h Y. ruckeri O1 biotype 2 (100415-1/4) culture (LB culture medium) was 
used for coating microtiter plates. Plates were washed three times in washing buffer (PBS pH 7.4 
with 0.1% Tween 20) and non-specific binding sites were blocked by incubation with 2% bovine 
serum albumin (BSA) in PBS for 1 h at room temperature. Serum samples from all groups were 
analyzed in duplicate wells. A diluted serum sample (100 µl, diluted 1:50 and 1:100) was added to 
the plate and incubated 12 h at 4 °C. After 3 times wash each well was incubated with mouse anti-
salmonid Ig (dilution 1:500; AbD Serotec Cat. MCA2182, Dusseldorf, Germany) for 1 h at room 
temperature on an orbital shaker (50 rpm) which was followed by 3 times washing and incubation 
with HRP (horseradish peroxidase) conjugated rabbit anti-mouse IgG (dilution 1:500; AbD Serotec 
Cat. STAR13B, Dusseldorf, Germany) for 1 h at room temperature as above. Chromogenic 
substrate TMB (AbD Serotec Cat. No. BUF042B, Dusseldorf, Germany) was then added, the 
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reaction stopped after 15 min by adding 1N HCl and OD read at 450 nm in an Epoch 
spectrophotometer (Biotek Instruments, Inc. Winooski, USA). 
Statistical analysis 
Normality test (Shapiro-Wilk) was conducted for the evaluation of the normal distribution of data 
within each group. The software GraphPad Prism 5 was used for creating graphs and performing 
statistical analysis. Mortality data from the infection experiment were analyzed by the Kaplan-
Meier test and differences among groups were tested using one way ANOVA with Tukey’s post 
hoc test after combining data from the replicates. ELISA data are presented from 1:50 serum 
dilutions and differences in antibody level (OD) between groups were tested using Student's t-test 
and Mann–Whitney U test. Groups were considered significantly different when P < 0.05.   
Results 
Survival following challenge 
No significant differences were found between duplicate tanks, which allowed pooling of mortality 
counts from these for further analysis. In order to detect the vaccine effect, the challenge dosage 
was adjusted at three different levels which elicited different mortality rates in vaccinated fish. The 
best survival rate was seen in fish vaccinated twice by dip vaccination (2 x dip). Fish receiving the 
low challenge dosage showed a higher survival rate compared to fish challenged with medium and 
high dosages. Survival rates were 97% and 92% in group 5 (2 x dip) and 7 (1 x dip + 1 x bath), 
respectively. Fish immunized once by 1 x dip and twice by 1 x dip + 1 x oral showed survival rates 
of 69% and 68%, respectively. Non-immunized control fish showed a survival rate of 49% which 
was not significantly different from fish exposed to 1 x oral and 2 x oral (44%) (Table 2) (Fig. 1A). 
Fish challenged with the medium dose exhibited 83%, 56%, and 49% survival  (groups exposed to 
2 x dip, 1 x dip + 1 x bath, and 1 x dip fish), respectively. The other vaccinated fish showed 31%, 
28%, 11%, and 5 % survival rates (1 x dip + 1 x oral, 1 x oral, control, and 2 x oral), respectively 
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(Table 2) and (Fig. 1B). Fish injected with the high dose of Y. ruckeri exhibited a relatively high 
mortality even in vaccinated fish. Non-immunized control fish and fish receiving 2 x oral 
vaccination exhibited comparable survival rate 5 % and 6 %, respectively. Fish dip immunized once 
(1 x dip) and orally immunized once (1 x oral) showed survival rates of 11 and 13%, respectively. 
Fish vaccinated once by dip and boostered orally (1 x dip + 1 x oral) or boostered by bath (1 x dip + 
1 x bath) exhibited survival rates of 22 % and 28 %, respectively. Fish dip vaccinated twice (2 x 
dip) showed the best resistance with a 40 % survival rate (Table 2) and (Fig. 1C).   
Antibody responses measured by ELISA 
At 52 days post-vaccination (pre-challenge) no significant differences were found with regard to 
antibody (IgM) levels between control, one time dip vaccination (1 x dip), and one time oral 
vaccination (1 x oral) (Fig. 2A).  Samples from fish taken 45 days after boostering (but before 
challenge) showed a slight but significant elevation of antibody levels in all groups which had 
received booster vaccination (2 x oral, 2 x dip, and 1 x dip + 1 x bath), except of fish which had 
received 1 x dip + 1 x oral, while control and one time vaccinated fish (1 x oral and 1 x dip) showed 
no change of antibody levels (Fig. 2B). Three weeks post-challenge (74 dpb) the antibody levels 
were elevated in all groups. In general, all groups exhibited higher antibody level compared to the 
level before challenge. Only two groups (1 x dip + 1 x oral) and (1 x dip + 1 x bath) exhibited 
significantly higher antibody responses compared to challenged but previously naïve (non-
vaccinated) fish (Fig. 2C).     
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Discussion  
It is generally recognized that the administration methods applied when vaccinating fish play a 
crucial role for the protection induced [5]. Injection vaccination provides a superior protection of 
rainbow trout towards Yersinia ruckeri compared to dip (short term immersion into a high 
concentration bacterin) and bath (long term bath in a low concentration bacterin) [16]. If adjuvants 
are combined with the vaccine antigens the protection after injection vaccination can be even higher 
[7]. However, small fish with a body weight of a few grams are not easily handled for injection 
vaccination and alternative administration methods or booster immunization may instead be 
optimized in order to achieve higher protection [5]. Thus, boostering by dip or bath has been shown 
to be effective both in the laboratory and in the field [8, 9]. Oral administration of vaccine may be 
an additional way to administer booster immunization but the precise effect of this methodology has 
remained unclear. The present investigation elucidated to which extent ERM vaccine antigens 
provided in fish feed confer  immunity of rainbow trout against Y. ruckeri infection. A primary oral 
vaccination of small rainbow trout - by feeding each fish over 2 × 5 days with a total of 0.1 ml 
vaccine in feed - only interrupted by a 5 day break - gave the fish a slight (statistically insignificant) 
protection against Y. ruckeri infection. However, if used as booster vaccination – after a primary dip 
vaccination in a bacterin diluted 1:10 for 30 sec - the oral administration provided led to a slightly 
increased protection when exposed to a medium or a high concentration of live Y. ruckeri bacteria. 
When an effective primary immunization against ERM has taken place it seems that boostering by 
the oral route may lift the response slightly. However, the study did also show that oral vaccination 
may not always be beneficial. If oral administration was used twice – without any prior strong 
immunization – a trend for a slightly (although statistically non-significant) decreased disease 
resistance (elevated mortality after challenge) was noted. It cannot be excluded that the low 
protection following two times oral antigen administration may be caused by induction of tolerance 
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to the pathogen. Induction of tolerance is a basic mechanism in the immune system [17, 18] as 
responses in a host against some antigens including self-antigens are clearly devastating. Therefore 
such auto-reactions must be avoided and during the ontogenetic development of the immune system 
the host organism exerts clonal deletion of self-reactive lymphocyte clones [19]. In addition, host 
reactions against microbiotas (associated with the skin, gills and gut) must be tightly regulated as 
exacerbated inflammatory reactions would be highly problematic as there is a constant bacterial 
exposure of outer or inner mucosal surfaces. Thus, the highly debilitating condition IBD 
(Inflammatory Bowel Disease), which is widespread in the industrialized part of the world, is 
caused by a severe inflammatory reaction of the host intestinal immune system against even benign 
gut microorganisms [20, 21]. Therefore, the host must be able to activate and apply immunological 
pathways in order to achieve tolerance to certain microorganisms which are recognized as non-
harmful, unable to penetrate the host or occur in that low densities that they are not perceived a 
danger by the host. These regulatory immune mechanisms may explain the inferior efficacies 
achieved after dermal vaccination against tuberculosis in certain areas where the human population 
is continuously exposed to environmental mycobacteria [22]. Correspondingly, mice orally 
immunized against antigens may exhibit a depressed reaction and immunity development towards 
these specific antigens [23]. Tolerance may include the action of regulatory T-cells with depression 
of cytokine expression [24] and possibly other immune mechanisms. It can therefore not be 
excluded that oral vaccination against ERM using feeding with a low concentration of formalin 
killed Y. ruckeri will initiate a state of immunological memory in rainbow trout but due to the 
evidently non-pathogenic nature of the killed antigens, combined with the extremely low 
concentrations, the tolerance pathway may be activated. To what extent the rainbow trout immune 
system applies Treg cells, immune regulating cytokines or other mechanisms in this process should 
be further investigated. It is generally found that immersion of fish into a bacterin merely elicits a 
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very low antibody reaction [25] and we have previously illustrated that antibody  levels in sera were 
elevated post-vaccination particularly in injection and twice immersion vaccinated fish. In the 
present study we saw merely a light (but statistically significant) elevation of Ig levels in boostered 
trout which were best protected groups but this may point to the importance of antibody based 
protection as corresponding to previous work on  the role of humoral immunity of rainbow trout in 
elimination Y. ruckeri [7, 8]. In addition, we showed in a previous study that the densities of IgM-
positive lymphocytes in trout spleens were significantly higher in fish immersed three times in 
bacterin compared to control fish [26]. In the present study the ELISA data showed that some 
immunological priming must have taken place as exposure to the live Y. ruckeri induced different 
antibody elevations in the differently primed groups – including fish immunized orally twice. 
Therefore protection is not solely reflected by antibody levels but must also involve various cellular 
reactions and regulatory mechanisms. This notion is supported by previous studies indicating that 
cellular mechanisms contribute to immunity against Y. ruckeri. Thus, expression levels of rainbow 
trout immune genes including T-cell markers (TcR, CD8α and CD4) were elevated in spleen tissue 
of rainbow trout dip-vaccinated against Y. ruckeri [27]. Further, expression levels of genes encoding 
CD4+ T (T-helper/TH), TH1, TH2, TH17, Tregs, and CD8+ T (cytotoxic T lymphocytes/CTLs) 
markers were up-regulated in challenged fish groups [7]. This indicates that protection of trout is 
regulated by an intricate network of immune factors in accordance with previous studies on 
vaccinated salmonids [28, 29, 30]. 
In conclusion the present study confirmed that dip vaccination combined with boostering by dip, 
bath or oral antigen presentation will elevate the protection against Y. ruckeri. However, it is 
noteworthy that a primary oral immunization followed by a corresponding oral booster left trout as 
susceptible as naïve control fish.  
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Tables: 
 
Table 1. Treatment groups. Seven duplicated groups were formed. Fish were immunized by oral 
and dip vaccination. Oral vaccination (AquaVac ERM oral) was conducted by administrating 
vaccine 0.1 ml/fish in feed (1% biomass per day) 2x5 days with a break of 5 days in between 
according to the manufacturer’s recommendations. Dip vaccination was performed by vaccinating 
fish for 30 s with AquaVac® RELERA (MSD Animal Health) vaccine (diluted 1:10) containing 
formalin-inactivated Yersinia ruckeri biotype 1 (5 × 109 cells/ml) and EX5 biogroup Y. ruckeri 
biotype 2 (5 × 109 cells/ml). Control fish were sham vaccinated by dipping into pure water or 
feeding them with commercial standard pelleted feed (Biomar A/S, Brande, Denmark). 
 
Tabel 2. Statistics of survival data presented in fig. 1. In order to elucidate differences between 
the treatment groups one way ANOVA with Tukey’s post hoc test was conducted. NS: no 
significant difference. *: p<0.5, **: p<0.01, ***: p<0.001. 
 
Figures: 
 
Figure 1: Percentage survival (Kaplan-Meier) of rainbow trout in different experimental groups 
following challenge 97 days post-1st vaccination by three different doses (low, medium, and high) 
with Yersinia ruckeri O1 biotype 2. Differences among groups were tested using one way ANOVA 
with Tukey’s post hoc test after combining data from the replicates. A: Low dose (6.5 x 104 
cfu/fish). B: Medium dose (6.5 x 105 cfu/fish). C: High dose (6.5 x 106 cfu/fish).   
 
Figure. 2. Yersinia ruckeri specific antibody (IgM) levels measured by ELISA (enzyme-linked 
immunosorbent assay). Each symbol represents a single fish (total of 10 fish/group were analyzed) 
and average antibody level in each group is shown by horizontal line. A: Pre-challenge (52 days 
post-1st vaccination). B: Pre-challenge (97 days post-1st vaccination/ 45 days post-booster). C: 
Three weeks post- exposure to live bacteria (126 days post-1st vaccination/ 74 days post-booster). 
Student's t-test and Mann–Whitney U test (*, P < 0.05). 
 
Supplementary figure: Schematic overview of the experimental setup.  
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Table 1 
 
Group no. Treatment Group ID 
1 Sham vaccinated control (No vaccination at all)  Control 
2 One time oral vaccination (AquaVac ERM oral) 1 x oral 
3 One time dip vaccination (AquaVac® RELERA) 1 x dip 
4 Two times oral vaccination (AquaVac ERM oral) 2 x oral 
5 Two times dip vaccination (AquaVac® RELERA) 2 x dip 
6 One time dip vaccination + One time oral vaccination  1 x dip + 1 x oral  
7 One time dip vaccination + One time bath vaccination  1 x dip + 1 x bath 
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Table 2: 
  
 
1 x oral 1 x dip. 2 x oral 2 x dip. 1 x dip. 
+ 1 x oral 
1 x dip. 
+ 1 x bath 
Percentage 
survival 
Low dose (6.5 x 104 cfu/fish) 
Control NS NS NS *** NS *** 49 
1 x oral 
 
NS NS *** NS *** 44 
1 x dip 
  
NS NS NS NS 69 
2 x oral 
   
*** NS *** 44 
2 x dip. 
    
NS NS 97 
1 x dip + 1 x oral 
    
NS 68 
1 x dip + 1 x bath     
  
92 
Medium dose (6.5 x 105 cfu/fish) 
Control NS ** NS *** NS *** 11 
1 x oral 
 
NS NS *** NS NS 28 
1 x dip 
  
*** * NS NS 49 
2 x oral 
   
*** NS *** 5 
2 x dip 
    
*** NS 83 
1 x dip + 1 x oral 
     
NS 31 
1 x dip + 1 x bath       56 
High dose (6.5 x 106 cfu/fish) 
Control NS NS NS ** NS NS 5 
1 x oral 
 
NS NS * NS NS 13 
1 x dip 
  
NS * NS NS 11 
2 x oral 
   
** NS NS 6 
2 x dip 
    
NS NS 40 
1 x dip + 1 x oral 
     
NS 22 
1 x dip + 1 x bath       28 
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Highlights for the manuscript 
 
• Vaccine induced protection of rainbow trout can be optimized by booster immunization 
either provided as dip (most effective), bath (less effective) or orally (least effective). 
• Oral immunization may be used as booster after dip vaccination but applied as a single oral 
application it induced merely a slight immune response. 
• Oral primary vaccination followed by an oral booster conferred no protection.  
